查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1942547

2026年全球无细胞DNA（cfDNA）试剂盒市场报告

Cell-Free DNA (cfDNA) Kits Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，无细胞DNA（cfDNA）试剂盒市场规模快速成长，预计将从2025年的18亿美元成长到2026年的20.2亿美元，复合年增长率（CAGR）为12.4%。过去几年的增长可归因于液态生物检体的日益普及、癌症诊断的增长、产前检测的增加、PCR和次世代定序（NGS）技术的发展以及实验室数量的增加。

预计未来几年，无细胞DNA (cfDNA) 试剂盒市场将快速成长，到2030年市场规模将达到32亿美元，复合年增长率(CAGR)为12.2%。预测期内的成长要素包括cfDNA试剂盒的技术创新、对非侵入性诊断的日益重视、人工智慧在分析领域的应用、新兴市场分子检测的扩张以及癌症生物标记研发投入的增加。预测期间的关键趋势包括高灵敏度DNA分离、自动化样本製备、与次世代定序(NGS)平台的整合、快速DNA萃取以及标准化cfDNA试剂盒。

预计未来几年，遗传疾病的日益普遍将推动无细胞DNA（cfDNA）检测试剂盒市场的成长。遗传疾病是由个体DNA改变引起的病理状况，这些改变是由一个或多个基因突变或染色体异常造成的。这些疾病发生率的上升主要是由于生活方式的改变和环境因素，例如污染和不合理的饮食，这些因素会导致基因突变或加重遗传疾病。无细胞DNA（cfDNA）检测试剂盒透过分析血液和其他体液中存在的DNA片段，能够早期、非侵入性地检测遗传异常。这项技术有助于快速诊断，并使医疗专业人员能够做出准确的治疗决策。例如，美国疾病管制与预防中心（CDC）在2024年11月报告称，美国大约每33名新生儿中就有1名患有先天性异常，其中许多与遗传因素有关。因此，遗传疾病的日益普遍正在推动对cfDNA检测试剂盒的需求。

cfDNA检测试剂盒市场的主要企业正致力于开发基于数位聚合酵素链锁反应（PCR）的绝对定量方法的创新产品，以提高cfDNA分析的灵敏度和准确性。基于数位PCR的绝对定量能够高度一致且精确地检测低频基因突变，使其适用于癌症诊断、产前检测和移植排斥反应监测等重要应用。例如，2024年6月，总部位于匈牙利的分子诊断公司Omixon推出了HoloGRAFT ONE，这是一款用于监测移植后供体来源游离DNA（dd-cfDNA）的研究试剂盒。该试剂盒利用专有的遗传标记和数位PCR技术来区分供体和受体DNA，并透过拷贝数变异（CNV）测量dd-cfDNA的绝对和相对含量。这项创新检测旨在实现移植排斥反应的早期检测，改善病患监测，并为临床医生提供准确的cfDNA数据，以支持移植后的个人化医疗。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球无细胞DNA（cfDNA）试剂盒市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 高灵敏度DNA分离
    • 样品製备流程自动化
    • 与次世代定序（NGS）平台集成
    • 快速DNA萃取
    • 标准化cfDNA试剂盒

第五章 终端用户产业市场分析

  • 医院
  • 研究所
  • 诊断检查室
  • 学术机构
  • 製药公司

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球无细胞DNA（cfDNA）试剂盒市场：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球无细胞DNA（cfDNA）试剂盒市场规模、比较及成长率分析
  • 全球无细胞DNA（cfDNA）试剂盒市场表现：规模与成长，2020-2025年
  • 全球无细胞DNA (cfDNA) 检测试剂盒市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场总量（TAM）

第九章 市场细分

  • 依产品类型
  • 无血浆DNA（cfDNA）试剂盒、无血清DNA（cfDNA）试剂盒、无尿液DNA（cfDNA）试剂盒、其他产​​品类型
  • 透过技术
  • 次世代定序（NGS）、聚合酵素链锁反应（PCR）、微阵列技术、数位聚合酵素链锁反应（PCR）
  • 透过使用
  • 癌症诊断、产前检测、移植排斥反应监测、非侵入性疾病检测
  • 透过分销管道
  • 直销、零售药局、线上销售、经销商
  • 最终用户
  • 医院、实验室、诊断实验室、学术机构
  • 按类型细分：血浆无细胞DNA试剂盒
  • 单链DNA萃取试剂盒、双链DNA萃取试剂盒、高灵敏度DNA萃取试剂盒、快速DNA萃取试剂盒
  • 按类型细分：无血清DNA检测试剂盒
  • 低容量DNA萃取试剂盒、高产量DNA萃取试剂盒、自动化DNA萃取试剂盒、手动DNA萃取试剂盒
  • 按类型细分：尿液游离DNA试剂盒
  • 早期检测DNA试剂盒、浓缩DNA试剂盒、高纯度DNA试剂盒、长期稳定DNA试剂盒
  • 按类型细分：其他产品类型
  • 唾液DNA检测试剂盒、脑脊髓液DNA检测试剂盒、羊水DNA检测试剂盒、组织来源DNA检测试剂盒

第十章 区域与国家分析

  • 全球无细胞DNA (cfDNA) 检测试剂盒市场：按地区划分，实际结果和预测，2020-2025年、2025-2030年预测、2035年预测
  • 全球无细胞DNA (cfDNA) 检测试剂盒市场：按国家/地区划分，实际值和预测值，2020-2025年、2025-2030年预测值、2035年预测值

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 无细胞DNA（cfDNA）试剂盒市场：竞争格局与市场份额，2024年
  • 无细胞DNA（cfDNA）试剂盒市场：公司估值矩阵
  • 无细胞DNA（cfDNA）试剂盒市场：公司简介
    • F. Hoffmann-La Roche Ltd
    • Thermo Fisher Scientific Inc.
    • Agilent Technologies Inc.
    • Illumina Inc.
    • Bio-Rad Laboratories Inc.

第37章：其他领先和创新企业

  • QIAGEN NV, Natera Inc., Myriad Genetics Inc., Guardant Health Inc., Bioneer Corporation, Streck Inc., Freenome Holdings Inc., GRAIL Inc., Zymo Research Corporation, Geneseeq Technology Inc, Covaris LLC, Active Motif Inc., Norgen Biotek Corp, AMSBIO LLC, EpiGentek Group Inc

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 无细胞DNA（cfDNA）试剂盒市场展望（2030年）：提供新机会的国家
  • 无细胞DNA（cfDNA）试剂盒市场展望（2030）：新兴细分市场机会
  • 无细胞DNA（cfDNA）试剂盒市场2030年：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MCFDC03_G26Q1

Cell-free DNA (cfDNA) kits are laboratory tools designed to isolate and analyze fragmented DNA circulating in blood or other body fluids. They support non-invasive genetic testing by providing high-quality DNA for applications such as prenatal screening, cancer diagnostics, and transplant monitoring. These kits simplify sample preparation and enhance accuracy in downstream molecular analysis.

The primary product types in the cell-free DNA (cfDNA) kits market include plasma cfDNA kits, serum cfDNA kits, urine cfDNA kits, and others. Plasma cfDNA kits are designed to isolate and analyze DNA fragments circulating in plasma, the liquid component of blood. Key technologies include next-generation sequencing (NGS), polymerase chain reaction (PCR), microarray technology, and digital PCR. Major applications encompass cancer diagnostics, prenatal testing, transplant rejection monitoring, and non-invasive disease detection. Distribution channels consist of direct sales, retail pharmacies, online platforms, and distributors, while end users include hospitals, research laboratories, diagnostic laboratories, and academic institutions.

Tariffs are impacting the cfDNA kits market by raising costs for imported reagents and extraction kits, affecting hospitals, research laboratories, and diagnostic centers. Regions like north america and europe, which import most cfDNA kits, are most affected. Positive impacts include incentivizing local production of high-quality kits and encouraging innovation in rapid, standardized extraction solutions.

The cell-free dna (cfdna) kits market research report is one of a series of new reports from The Business Research Company that provides cell-free dna (cfdna) kits market statistics, including cell-free dna (cfdna) kits industry global market size, regional shares, competitors with a cell-free dna (cfdna) kits market share, detailed cell-free dna (cfdna) kits market segments, market trends and opportunities, and any further data you may need to thrive in the cell-free dna (cfdna) kits industry. This cell-free dna (cfdna) kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell-free dna (cfdna) kits market size has grown rapidly in recent years. It will grow from $1.8 billion in 2025 to $2.02 billion in 2026 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to rising adoption of liquid biopsy, growth in cancer diagnostics, increasing prenatal testing, development of PCR and NGS technologies, growth in research laboratories.

The cell-free dna (cfdna) kits market size is expected to see rapid growth in the next few years. It will grow to $3.2 billion in 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to technological innovations in cfDNA kits, increasing focus on non-invasive diagnostics, AI integration in analysis, expansion of molecular testing in emerging markets, increased R&D in cancer biomarkers. Major trends in the forecast period include high-sensitivity dna isolation, automation of sample preparation, integration with ngs platforms, rapid dna extraction, standardized cfdna kits.

The increasing prevalence of genetic disorders is expected to drive the growth of the cell-free DNA (cfDNA) kits market in the coming years. Genetic disorders are medical conditions caused by alterations in a person's DNA, which can result from mutations in one or more genes, or chromosomal abnormalities. The rising occurrence of these disorders is largely due to lifestyle changes and environmental factors such as pollution and poor diet, which can either cause genetic mutations or worsen inherited conditions. Cell-free DNA (cfDNA) kits enable early, non-invasive detection of genetic abnormalities by analyzing DNA fragments present in blood or other body fluids. This technology facilitates quicker diagnoses and allows healthcare providers to make accurate treatment decisions. For example, the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, reported in November 2024 that about 1 in every 33 newborns in the U.S. is born with a birth defect, many of which are genetically related. As a result, the increasing prevalence of genetic disorders is fueling demand for cfDNA kits.

Leading companies in the cfDNA kits market are concentrating on developing innovative products that use digital polymerase chain reaction (PCR)-based absolute quantification to enhance the sensitivity and accuracy of cfDNA analysis. Digital PCR-based absolute quantification allows for the precise detection of low-frequency genetic variants with improved consistency, making it suitable for critical applications such as cancer diagnostics, prenatal testing, and monitoring transplant rejection. For example, in June 2024, Omixon, a molecular diagnostics company based in Hungary, introduced HoloGRAFT ONE, a research-use-only kit designed to monitor donor-derived cell-free DNA (dd-cfDNA) post-transplant. This kit utilizes proprietary genetic markers and digital PCR to differentiate donor DNA from the recipient's DNA, measuring both absolute and relative amounts of dd-cfDNA through copy-number variants. The goal of this innovative test is to enable the early detection of transplant rejection, improve patient monitoring, and support personalized post-transplant care by providing clinicians with precise cfDNA data.

In November 2025, Natera Inc., a US-based genetic testing and diagnostics firm, acquired specific reproductive health assets from Invitae for an undisclosed sum. Through this acquisition, Natera intends to broaden its molecular diagnostic offerings and expand its customer reach by incorporating Invitae's non-invasive prenatal screening and carrier screening operations, allowing greater access to personalized genetic testing and diagnostic services. Invitae Corporation is a US-based medical genetics company focused on cell-free DNA (cfDNA) testing kits for non-invasive prenatal testing and oncology purposes.

Major companies operating in the cell-free dna (cfdna) kits market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V, Natera Inc., Myriad Genetics Inc., Guardant Health Inc., Bioneer Corporation, Streck Inc., Freenome Holdings Inc., GRAIL Inc., Zymo Research Corporation, Geneseeq Technology Inc, Covaris LLC, Active Motif Inc., Norgen Biotek Corp, AMSBIO LLC, EpiGentek Group Inc., Paragon Genomics Inc., Suzhou Beaver Biomedical Engineering.

North America was the largest region in the cell-free DNA (cfDNA) kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell-free dna (cfdna) kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell-free dna (cfdna) kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cell-free DNA (cfDNA) kits market consists of revenues earned by entities by providing services such as purification services, bulk services, quality control (QC) services, data integration services, and custom biomarker discovery services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell-free DNA (cfDNA) kits market also includes sales of plasma separation consumables, liquid biopsy assay kits, serum preparation kits, concentration kits, and bisulfite conversion and methylation kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell-Free DNA (cfDNA) Kits Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses cell-free dna (cfdna) kits market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell-free dna (cfdna) kits ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell-free dna (cfdna) kits market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Plasma Cell-Free DNA (Cfdna) Kits; Serum Cell-Free DNA (Cfdna) Kits; Urine Cell-Free DNA (Cfdna) Kits; Other Product Types
  • 2) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Microarray Technology; Digital Polymerase Chain Reaction(PCR)
  • 3) By Application: Cancer Diagnostics; Prenatal Testing; Transplant Rejection Monitoring; Non-Invasive Disease Detection
  • 4) By Distribution Channel: Direct Sales; Retail Pharmacies; Online Sales; Distributors
  • 5) By End User: Hospitals; Research Laboratories; Diagnostic Laboratories; Academic Institutions
  • Subsegments:
  • 1) By Plasma Cell-Free DNA Kits: Single-Stranded DNA Kits; Double-Stranded DNA Kits; High-Sensitivity DNA Kits; Rapid Extraction DNA Kits
  • 2) By Serum Cell-Free DNA Kits: Low-Volume DNA Kits; High-Yield DNA Kits; Automated DNA Kits; Manual Extraction DNA Kits
  • 3) By Urine Cell-Free DNA Kits: Early Detection DNA Kits; Concentration DNA Kits; High-Purity DNA Kits; Long-Term Stability DNA Kits
  • 4) By Other Product Types: Saliva DNA Kits; Cerebrospinal Fluid DNA Kits; Amniotic Fluid DNA Kits; Tissue-Derived DNA Kits
  • Companies Mentioned: F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; Illumina Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V; Natera Inc.; Myriad Genetics Inc.; Guardant Health Inc.; Bioneer Corporation; Streck Inc.; Freenome Holdings Inc.; GRAIL Inc.; Zymo Research Corporation; Geneseeq Technology Inc; Covaris LLC; Active Motif Inc.; Norgen Biotek Corp; AMSBIO LLC; EpiGentek Group Inc.; Paragon Genomics Inc.; Suzhou Beaver Biomedical Engineering.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Cell-Free DNA (cfDNA) Kits Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Cell-Free DNA (cfDNA) Kits Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Cell-Free DNA (cfDNA) Kits Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Cell-Free DNA (cfDNA) Kits Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 High-Sensitivity Dna Isolation
    • 4.2.2 Automation Of Sample Preparation
    • 4.2.3 Integration With Ngs Platforms
    • 4.2.4 Rapid Dna Extraction
    • 4.2.5 Standardized Cfdna Kits

5. Cell-Free DNA (cfDNA) Kits Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Research Laboratories
  • 5.3 Diagnostic Laboratories
  • 5.4 Academic Institutions
  • 5.5 Pharmaceutical Companies

6. Cell-Free DNA (cfDNA) Kits Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cell-Free DNA (cfDNA) Kits Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Cell-Free DNA (cfDNA) Kits PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Cell-Free DNA (cfDNA) Kits Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Cell-Free DNA (cfDNA) Kits Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Cell-Free DNA (cfDNA) Kits Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cell-Free DNA (cfDNA) Kits Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cell-Free DNA (cfDNA) Kits Market Segmentation

  • 9.1. Global Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Plasma Cell-Free DNA (Cfdna) Kits, Serum Cell-Free DNA (Cfdna) Kits, Urine Cell-Free DNA (Cfdna) Kits, Other Product Types
  • 9.2. Global Cell-Free DNA (cfDNA) Kits Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray Technology, Digital Polymerase Chain Reaction(PCR)
  • 9.3. Global Cell-Free DNA (cfDNA) Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cancer Diagnostics, Prenatal Testing, Transplant Rejection Monitoring, Non-Invasive Disease Detection
  • 9.4. Global Cell-Free DNA (cfDNA) Kits Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Direct Sales, Retail Pharmacies, Online Sales, Distributors
  • 9.5. Global Cell-Free DNA (cfDNA) Kits Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Research Laboratories, Diagnostic Laboratories, Academic Institutions
  • 9.6. Global Cell-Free DNA (cfDNA) Kits Market, Sub-Segmentation Of Plasma Cell-Free DNA Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Stranded DNA Kits, Double-Stranded DNA Kits, High-Sensitivity DNA Kits, Rapid Extraction DNA Kits
  • 9.7. Global Cell-Free DNA (cfDNA) Kits Market, Sub-Segmentation Of Serum Cell-Free DNA Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Low-Volume DNA Kits, High-Yield DNA Kits, Automated DNA Kits, Manual Extraction DNA Kits
  • 9.8. Global Cell-Free DNA (cfDNA) Kits Market, Sub-Segmentation Of Urine Cell-Free DNA Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Early Detection DNA Kits, Concentration DNA Kits, High-Purity DNA Kits, Long-Term Stability DNA Kits
  • 9.9. Global Cell-Free DNA (cfDNA) Kits Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Saliva DNA Kits, Cerebrospinal Fluid DNA Kits, Amniotic Fluid DNA Kits, Tissue-Derived DNA Kits

10. Cell-Free DNA (cfDNA) Kits Market Regional And Country Analysis

  • 10.1. Global Cell-Free DNA (cfDNA) Kits Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Cell-Free DNA (cfDNA) Kits Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cell-Free DNA (cfDNA) Kits Market

  • 11.1. Asia-Pacific Cell-Free DNA (cfDNA) Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cell-Free DNA (cfDNA) Kits Market

  • 12.1. China Cell-Free DNA (cfDNA) Kits Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cell-Free DNA (cfDNA) Kits Market

  • 13.1. India Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cell-Free DNA (cfDNA) Kits Market

  • 14.1. Japan Cell-Free DNA (cfDNA) Kits Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cell-Free DNA (cfDNA) Kits Market

  • 15.1. Australia Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cell-Free DNA (cfDNA) Kits Market

  • 16.1. Indonesia Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cell-Free DNA (cfDNA) Kits Market

  • 17.1. South Korea Cell-Free DNA (cfDNA) Kits Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cell-Free DNA (cfDNA) Kits Market

  • 18.1. Taiwan Cell-Free DNA (cfDNA) Kits Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cell-Free DNA (cfDNA) Kits Market

  • 19.1. South East Asia Cell-Free DNA (cfDNA) Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cell-Free DNA (cfDNA) Kits Market

  • 20.1. Western Europe Cell-Free DNA (cfDNA) Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cell-Free DNA (cfDNA) Kits Market

  • 21.1. UK Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cell-Free DNA (cfDNA) Kits Market

  • 22.1. Germany Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cell-Free DNA (cfDNA) Kits Market

  • 23.1. France Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cell-Free DNA (cfDNA) Kits Market

  • 24.1. Italy Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cell-Free DNA (cfDNA) Kits Market

  • 25.1. Spain Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cell-Free DNA (cfDNA) Kits Market

  • 26.1. Eastern Europe Cell-Free DNA (cfDNA) Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cell-Free DNA (cfDNA) Kits Market

  • 27.1. Russia Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cell-Free DNA (cfDNA) Kits Market

  • 28.1. North America Cell-Free DNA (cfDNA) Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cell-Free DNA (cfDNA) Kits Market

  • 29.1. USA Cell-Free DNA (cfDNA) Kits Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cell-Free DNA (cfDNA) Kits Market

  • 30.1. Canada Cell-Free DNA (cfDNA) Kits Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cell-Free DNA (cfDNA) Kits Market

  • 31.1. South America Cell-Free DNA (cfDNA) Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cell-Free DNA (cfDNA) Kits Market

  • 32.1. Brazil Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cell-Free DNA (cfDNA) Kits Market

  • 33.1. Middle East Cell-Free DNA (cfDNA) Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cell-Free DNA (cfDNA) Kits Market

  • 34.1. Africa Cell-Free DNA (cfDNA) Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Cell-Free DNA (cfDNA) Kits Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cell-Free DNA (cfDNA) Kits Market Regulatory and Investment Landscape

36. Cell-Free DNA (cfDNA) Kits Market Competitive Landscape And Company Profiles

  • 36.1. Cell-Free DNA (cfDNA) Kits Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Cell-Free DNA (cfDNA) Kits Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Cell-Free DNA (cfDNA) Kits Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Cell-Free DNA (cfDNA) Kits Market Other Major And Innovative Companies

  • QIAGEN N.V, Natera Inc., Myriad Genetics Inc., Guardant Health Inc., Bioneer Corporation, Streck Inc., Freenome Holdings Inc., GRAIL Inc., Zymo Research Corporation, Geneseeq Technology Inc, Covaris LLC, Active Motif Inc., Norgen Biotek Corp, AMSBIO LLC, EpiGentek Group Inc

38. Global Cell-Free DNA (cfDNA) Kits Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cell-Free DNA (cfDNA) Kits Market

40. Cell-Free DNA (cfDNA) Kits Market High Potential Countries, Segments and Strategies

  • 40.1 Cell-Free DNA (cfDNA) Kits Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Cell-Free DNA (cfDNA) Kits Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Cell-Free DNA (cfDNA) Kits Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer